Hydrogel containing heparin-poloxamer compound for anastomosis of blood vessel and preparation method thereof
A hydrogel and composite technology, used in applications, surgery, surgical adhesives, etc., can solve the problems of inability to achieve microvascular anastomosis, high cost of human albumin, increased risk of vascular embolism, etc. Smooth flow, reduce the risk of vascular embolism, cost-effective effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0024] Example 1. Preparation of Y-X-Y type heparin-poloxamer complex hydrogel
[0025] There are various structural combinations of heparin-poloxamer complexes. In this example, poloxamer 407 and low-molecular-weight heparin sodium were used as raw materials to synthesize Y-X-Y type heparin-poloxamer complexes, and then heparin-poloxamer complexes were prepared. Poloxamer complex hydrogel.
[0026] Synthesis of Y-X-Y type heparin-poloxamer complex: Weigh 12 g of poloxamer 407 (relative molecular weight M=12000, where a=c=101, b=56), and add 2 mmol of Succinic anhydride, 2mmol of 4-dimethylaminopyridine and 0.55ml triethylamine are dissolved in 200ml of dioxane, stirred and reacted overnight to obtain a carboxyl-terminal poloxamer, which is used as a reactant, Using the 1-ethyl-3,3-dimethylaminopropylcarbodiimide (EDC) / N-hydroxyl imide (NHS) method, 10 g of low-molecular-weight heparin sodium was added, and the reaction was stirred for 24 hours. The reaction product was dial...
Embodiment 2
[0029] Example 2, Preparation of Y-g-X-g-Y heparin-poloxamer complex hydrogel
[0030] In this example, poloxamer 188 and enoxaparin were used as raw materials to synthesize a Y-g-X-g-Y type heparin-poloxamer complex, and then prepare a heparin-poloxamer complex hydrogel.
[0031] Synthesis of Y-g-X-g-Y type heparin-poloxamer complex: Poloxamer 188 (M=8350, a=c=80, b=27) 2mmol and 3ml caprolactone under Sn-Oct as catalyst and Ar gas protection Polymerization was carried out in a vacuum state, and the reaction was stopped after stirring for 24 hours. The reaction product was dissolved in 10 ml of chloroform, and 10 times the volume of diethyl ether was added to precipitate, filtered, and repeated twice to purify the obtained product. The product was stirred and reacted for 24 hours under 4mmol succinic anhydride (SA), 2mmol 4-dimethylaminopyridine (DMAP), 0.55ml triethylamine (TEA), and 30ml dioxane as a solvent, dissolved in 10ml chloroform, Add 10 times the volume of diethyl...
Embodiment 3
[0033] Example 3. Preparation of X-g-Y type heparin-poloxamer complex hydrogel
[0034] In this example, poloxamer 338 and deteparin were used as raw materials to synthesize an X-g-Y type heparin-poloxamer complex, and then a heparin-poloxamer complex hydrogel was prepared.
[0035] Synthesis of X-g-Y type heparin-poloxamer complex: Poloxamer 338 (M=15000, a=c=141, b=44) 15g, in 100ml dichloromethane as solvent, 0.6ml triethylamine as catalyst under the action of 2mmol React at room temperature for 4h, then add 2.5mmol ethylenediamine and continue the reaction for 12h. -Hydroxyl imide (NHS) method, react it with carboxyl group of 10g enoxaparin, stir for 24 hours, the final product of the reaction is dialyzed for 3 days through a dialysis bag, freeze-dried to form a new material called deteparin- Ethylenediamine-poloxamer.
[0036] Preparation of X-g-Y type heparin-poloxamer complex hydrogel: Weigh 1.5g of the heparin-poloxamer complex synthesized above, disperse it in 5ml...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com